Clinipace Acquires Choice Pharma, a Pan-Asia CRO

Clinipace Worldwide, a global CRO headquartered in North Carolina, has closed its acquisition of Choice Pharma, a pan-Asian contract research organization. Choice has offices in China (Shanghai, Beijing, Guangzhou), Taiwan, Hong Kong, South Korea, Vietnam, Singapore and Malaysia. It is headquartered in Taiwan. Clinipace said its clients want access to Asian CRO services, making Choice an attractive investment. Terms were not disclosed. More details.... Share this with colleagues: // //